Sheets Smith Wealth Management Abb Vie Inc. Transaction History

Sheets Smith Wealth Management

$828 Million
Q2 2024

A detailed history of Sheets Smith Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 15,520 shares of ABBV stock, worth $3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

15,520

Previous 15,676 1.0%

Holding current value

$3 Million

Previous $2.85 Million 6.76%

% of portfolio

0.32%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $24,147 - $28,198	-156 Reduced 1.0%	15,520 $2.66 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $11,666 - $13,293	-73 Reduced 0.46%	15,676 $2.85 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $69,075 - $77,794	-502 Reduced 3.09%	15,749 $2.44 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $178,877 - $207,076	-1,339 Reduced 7.61%	16,251 $2.42 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $4,107 - $5,111	-31 Reduced 0.18%	17,590 $2.37 Million
Q1 2023 May 26, 2023	BUY	$144.61 - $166.54 $2.53 Million - $2.91 Million	17,462 Added 10982.39%	17,621 $2.81 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $2.54 Million - $2.92 Million	-17,544 Reduced 99.1%	159 $25,000
Q4 2022 Mar 08, 2023	SELL	$138.31 - $165.87 $8,160 - $9,786	-59 Reduced 0.33%	17,703 $2.86 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $407,729 - $467,639	3,038 Added 20.63%	17,762 $2.38 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $606,491 - $771,048	-4,407 Reduced 23.04%	14,724 $2.26 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $76,944 - $95,466	-583 Reduced 2.96%	19,131 $3.1 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $7,305 - $9,243	68 Added 0.35%	19,714 $2.67 Million
Q3 2021 Oct 15, 2021	SELL	$106.4 - $120.78 $16,917 - $19,204	-159 Reduced 0.8%	19,646 $2.12 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $8,732 - $9,728	-83 Reduced 0.42%	19,805 $2.23 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $36,725 - $40,430	359 Added 1.84%	19,888 $2.15 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $41,210 - $55,639	512 Added 2.69%	19,529 $2.09 Million
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $48,710 - $57,170	567 Added 3.07%	19,017 $1.67 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $102,864 - $137,648	1,402 Added 8.22%	18,450 $1.81 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $29,347 - $44,494	455 Added 2.74%	17,048 $1.3 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $74,077 - $92,686	1,027 Added 6.6%	16,593 $1.47 Million
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $220,555 - $265,171	-3,502 Reduced 18.37%	15,566 $1.18 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $1,839 - $2,351	28 Added 0.15%	19,068 $1.39 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $5,399 - $6,355	70 Added 0.37%	19,040 $1.53 Million
Q4 2018 Jan 11, 2019	BUY	$77.85 - $96.01 $125,182 - $154,384	1,608 Added 9.26%	18,970 $1.75 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $6,490 - $7,215	-73 Reduced 0.42%	17,362 $1.64 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $5,386 - $6,373	60 Added 0.35%	17,435 $1.62 Million
Q1 2018 Apr 09, 2018	SELL	$92.01 - $123.21 $1.06 Million - $1.42 Million	-11,526 Reduced 39.88%	17,375 $1.65 Million
Q4 2017 Jan 12, 2018	SELL	$89.56 - $98.21 $51,049 - $55,979	-570 Reduced 1.93%	28,901 $2.8 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $2.06 Million - $2.63 Million	29,471	29,471 $2.62 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Abb Vie Inc. Transaction History